Related references
Note: Only part of the references are listed.Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
Dorthe Holdhof et al.
ACTA NEUROPATHOLOGICA (2021)
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK)
Karolina Nemes et al.
EUROPEAN JOURNAL OF CANCER (2021)
Loss of BRG1 (SMARCA4) Immunoexpression in a Pediatric Non-Central Nervous System Tumor Cohort
Jessica Saunders et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2020)
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines
Marc Tischkowitz et al.
CLINICAL CANCER RESEARCH (2020)
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
Aurelie Auguste et al.
CELLS (2020)
Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism
Krystal Ann Orlando et al.
ELIFE (2020)
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting
Joshua Pan et al.
NATURE GENETICS (2019)
BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors
Xiaofeng Wang et al.
NATURE COMMUNICATIONS (2019)
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration
Hye-Jung E. Chun et al.
CELL REPORTS (2019)
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors
Amaury Leruste et al.
CANCER CELL (2019)
Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)
Christine Bookhout et al.
NEUROPATHOLOGY (2018)
Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous
Emilia M. Pinto et al.
ACTA NEUROPATHOLOGICA (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
Kyle Ellrott et al.
CELL SYSTEMS (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation
Brittany C. Michel et al.
NATURE CELL BIOLOGY (2018)
Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm
W. Glenn McCluggage et al.
HISTOPATHOLOGY (2017)
Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities
Akihiko Yoshida et al.
MODERN PATHOLOGY (2017)
Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas
Inga-Marie Schaefer et al.
MODERN PATHOLOGY (2017)
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters
Robert T. Nakayama et al.
NATURE GENETICS (2017)
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
Wilfrid Richer et al.
ONCOTARGET (2017)
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
Anthony N. Karnezis et al.
JOURNAL OF PATHOLOGY (2016)
SMARCA4-Mutated Atypical Teratoid/Rhabdoid Tumor with Retained BRG1 Expression
Julien Masliah-Planchon et al.
PEDIATRIC BLOOD & CANCER (2016)
Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor
Somayyeh Fahiminiya et al.
ONCOTARGET (2016)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways
Hye-Jung E. Chun et al.
CANCER CELL (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
Francois Le Loarer et al.
NATURE GENETICS (2015)
Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
Cigall Kadoch et al.
SCIENCE ADVANCES (2015)
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
F. Favero et al.
ANNALS OF ONCOLOGY (2015)
SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis
Martin Hasselblatt et al.
ACTA NEUROPATHOLOGICA (2014)
No small surprise-small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour
William D. Foulkes et al.
JOURNAL OF PATHOLOGY (2014)
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
Pilar Ramos et al.
NATURE GENETICS (2014)
Germ line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type
Leora Witkowski et al.
NATURE GENETICS (2014)
Comprehensive analysis of DNA methylation data with RnBeads
Yassen Assenov et al.
NATURE METHODS (2014)
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
Gregory R. Hoffman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Familial rhabdoid tumour 'avant la lettre'from pathology review to exome sequencing and back again
Leora Witkowski et al.
JOURNAL OF PATHOLOGY (2013)
Extracranial rhabdoid tumours: what we have learned so far and future directions
Bernadette Brennan et al.
LANCET ONCOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system
Christelle Dufour et al.
CANCER (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
Ryan S. Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
DNA methylation at the Igf2/H19 imprinting control region is associated with cerebellum mass in outbred mice
Ruth Pidsley et al.
MOLECULAR BRAIN (2012)
Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression
Martin Hasselblatt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor
Franck Bourdeaut et al.
CLINICAL CANCER RESEARCH (2011)
Spectrum of SMARCB1/INI1 Mutations in Familial and Sporadic Rhabdoid Tumors
Katherine W. Eaton et al.
PEDIATRIC BLOOD & CANCER (2011)
Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome
Reinhard Schneppenheim et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome
Michael C. Fruehwald et al.
PEDIATRIC BLOOD & CANCER (2006)
Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5
CWM Roberts et al.
CANCER CELL (2002)
dbSNP: the NCBI database of genetic variation
ST Sherry et al.
NUCLEIC ACIDS RESEARCH (2001)
Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice
CWM Roberts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
